Clinical Trial Update: Pharmacovigilance in Gerontopsychiatric Patients [Phase 3]

View source ↗

Summary

A Phase 3 pharmacovigilance trial in gerontopsychiatric patients has been terminated; the study focused on dementia and depression with related conditions such …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Dementia
• Major Depressive Disorder
• Psychosomatic Disorders
• Schizophrenia

Snippet

Sponsor: Hannover Medical School | Conditions: Dementia, Depression | Phase 3 | Status: TERMINATED